Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract.
作者信息
Finall A I, McIntosh S A, Thompson W D
机构信息
Department of Histopathology, University Hospital of Wales, Cardiff and Vale NHS Trust, Cardiff CF14 4XW.
出版信息
BMJ. 2006 Dec 23;333(7582):1293-4. doi: 10.1136/bmj.39044.460023.BE.
Abstract
摘要
相似文献
1
Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract.
BMJ. 2006 Dec 23;333(7582):1293-4. doi: 10.1136/bmj.39044.460023.BE.
2
Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).
Am J Ther. 1998 May;5(3):181-7. doi: 10.1097/00045391-199805000-00009.
3
Grade II-anaphylaxis after subcutaneous injection of mistletoe extract.
Contact Dermatitis. 2021 Oct;85(4):462-465. doi: 10.1111/cod.13880. Epub 2021 Jun 30.
4
[Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Arzneimittelforschung. 2004;54(8):456-66. doi: 10.1055/s-0031-1296999.
5
Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
Arzneimittelforschung. 1999 Apr;49(4):366-73. doi: 10.1055/s-0031-1300428.
6
Abnoba-viscum (mistletoe extract) in metastatic colorectal carcinoma resistant to 5-fluorouracil and leucovorin-based chemotherapy.
Med Oncol. 2004;21(3):251-4. doi: 10.1385/MO:21:3:251.
7
8
Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
J Altern Complement Med. 2018 Sep/Oct;24(9-10):954-961. doi: 10.1089/acm.2018.0159.
9
[Added to conventional therapy, what does mistletoe extract contribute in breast carcinoma].
MMW Fortschr Med. 2004 Mar 25;146(13):58.
10
Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
Forsch Komplementarmed Klass Naturheilkd. 2004 Aug;11 Suppl 1:23-9. doi: 10.1159/000080572.
引用本文的文献
1
Safety Considerations for Natural Products with Adaptogenic and Immunomodulating Activities.
Pharmaceuticals (Basel). 2025 Aug 15;18(8):1208. doi: 10.3390/ph18081208.
2
The Anti-Inflammatory Activity of .
Plants (Basel). 2023 Mar 27;12(7):1460. doi: 10.3390/plants12071460.
3
Mistletoe as a treatment for cancer.
BMJ. 2006 Dec 23;333(7582):1282-3. doi: 10.1136/bmj.39055.493958.80.
本文引用的文献
1
Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.
Br J Cancer. 2004 Jan 12;90(1):65-9. doi: 10.1038/sj.bjc.6601463.
2
Mistletoe for cancer? A systematic review of randomised clinical trials.
Int J Cancer. 2003 Nov 1;107(2):262-7. doi: 10.1002/ijc.11386.
3
Mistletoe in cancer - a systematic review on controlled clinical trials.
Eur J Med Res. 2003 Mar 27;8(3):109-19.
4
Hypereosinophilia induced by high-dose intratumoral and peritumoral mistletoe application to a patient with pancreatic carcinoma.
J Altern Complement Med. 2000 Aug;6(4):305-10. doi: 10.1089/10755530050120664.
5
Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).
Am J Ther. 1998 May;5(3):181-7. doi: 10.1097/00045391-199805000-00009.
6
7
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.
Arthritis Rheum. 1997 Sep;40(9):1725. doi: 10.1002/art.1780400928.
8
Post-steroid panniculitis in acute leukemia.
N Engl J Med. 1971 Feb 18;284(7):366-7. doi: 10.1056/NEJM197102182840706.
9
Histopathology of the skin in dermatomyositis. A histopathologic study of 55 cases.
Arch Dermatol. 1968 Jun;97(6):640-50.
10
Factitial traumatic panniculitis.
J Am Acad Dermatol. 1985 Dec;13(6):988-94. doi: 10.1016/s0190-9622(85)70250-2.
Zotero 插件